$4.48 Billion is the total value of Hillhouse Capital Management's 34 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BIDU | BAIDU INCspon adr rep a | $202,737,000 | -9.7% | 1,233,120 | 0.0% | 4.52% | -1.4% | |
| WUBA | 58 COM INCspon adr rep a | $155,413,000 | -41.3% | 5,550,451 | 0.0% | 3.47% | -35.8% | |
| SINA | SINA CORPord | $86,334,000 | -17.7% | 1,420,208 | 0.0% | 1.93% | -10.1% | |
| SOHU | SOHU COM INC | $55,943,000 | -23.4% | 1,650,727 | 0.0% | 1.25% | -16.4% | |
| TAL | TAL ED GROUP | $42,014,000 | -1.0% | 598,920 | 0.0% | 0.94% | +8.1% | |
| ITCI | INTRA CELLULAR THERAPIES INC | $15,090,000 | -1.0% | 1,000,000 | 0.0% | 0.34% | +8.4% | |
| LN | LINE CORPsponsored adr | $11,455,000 | -29.7% | 336,800 | 0.0% | 0.26% | -23.1% | |
| CCJ | CAMECO CORP | $10,739,000 | +22.3% | 1,025,700 | 0.0% | 0.24% | +34.1% | |
| ACIU | AC IMMUNE SA | $7,139,000 | -21.2% | 550,000 | 0.0% | 0.16% | -14.1% | |
| CLSD | CLEARSIDE BIOMEDICAL INC | $5,364,000 | -48.5% | 600,000 | 0.0% | 0.12% | -43.7% | |
| SFUN | FANG HLDGS LTDadr | $4,920,000 | -26.9% | 1,500,000 | 0.0% | 0.11% | -20.3% | |
| PYPL | PAYPAL HLDGS INC | $2,968,000 | -3.6% | 75,186 | 0.0% | 0.07% | +4.8% | |
| XNET | XUNLEI LTDsponsored adr | $1,556,000 | -28.4% | 403,041 | 0.0% | 0.04% | -20.5% | |
| LC | LENDINGCLUB CORP | $525,000 | -15.0% | 100,000 | 0.0% | 0.01% | -7.7% | |
| MCRB | SERES THERAPEUTICS INC | $209,000 | -19.3% | 21,093 | 0.0% | 0.01% | 0.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MONDELEZ INTL INC | 22 | Q3 2018 | 44.4% |
| JD COM INC | 19 | Q2 2019 | 80.2% |
| SOHU COM INC | 19 | Q1 2018 | 13.4% |
| 58 COM INC | 18 | Q3 2018 | 7.8% |
| TAL EDUCATION GROUP | 18 | Q2 2019 | 4.4% |
| CTRIP COM INTL LTD | 17 | Q2 2017 | 28.4% |
| BEIGENE LTD | 14 | Q2 2019 | 25.2% |
| MELCO RESORT ENTERTAINMENT L | 14 | Q3 2018 | 6.4% |
| CAMECO CORP | 14 | Q4 2017 | 2.2% |
| ENSTAR GROUP LIMITED | 12 | Q2 2019 | 21.9% |
View Hillhouse Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| China Jo-Jo Drugstores Holdings, Inc. | February 14, 2023 | 403,334 | 4.7% |
| TScan Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Enfusion, Inc. | February 14, 2022 | 4,975,183 | 7.6% |
| Enstar Group LTD | July 19, 2021 | ? | ? |
| Zoom Video Communications, Inc. | February 16, 2021 | 2,981,265 | 1.5% |
| NIO Inc. | February 14, 2020 | ? | ? |
| Sea Ltd | February 14, 2020 | 4,300,000 | 2.3% |
| Uxin Ltd | February 14, 2020 | 21,733,023 | 2.6% |
| Apellis Pharmaceuticals, Inc. | February 14, 2019 | 2,098,581 | 3.7% |
| iQIYI, Inc. | February 14, 2019 | 240,191,174 | 11.0% |
View Hillhouse Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-03-05 |
| 13F-NT | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 4 | 2024-02-01 |
| 3 | 2024-01-25 |
| 13F-NT | 2023-11-14 |
| 13F-NT | 2023-08-14 |
View Hillhouse Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.